We are live on ! Find out more
AI

Analytic Investors Portfolio holdings

AUM $8.93B
1-Year Est. Return 13.54%
This Fund
S&P 500
This Quarter Est. Return
-1.9%
1 Year Est. Return
+13.54%
3 Year Est. Return
+42.14%
5 Year Est. Return
10 Year Est. Return
AUM
$7.48B
AUM Growth
+$359M
Cap. Flow
+$584M
Cap. Flow %
7.8%
Top 10 Hldgs %
21.43%
Holding
699
New
142
Increased
200
Reduced
165
Closed
156

Top Buys

Rank Stock Value
1
MKC icon
McCormick & Company Non-Voting
MKC
+$89.6M
2
SYY icon
Sysco
SYY
+$82.3M
3
CAH icon
Cardinal Health
CAH
+$72M
4
LMT icon
Lockheed Martin
LMT
+$70M
5
T icon
AT&T
T
+$47.1M

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$91.5M
2
PRE
PARTNERRE LTD
PRE
+$65.4M
3
ETR icon
Entergy
ETR
+$54.8M
4
IBM icon
IBM
IBM
+$48.2M
5
LLY icon
Eli Lilly
LLY
+$36.7M

Sector Composition

Rank Sector Weight
1 Consumer Staples 30.79%
2 Healthcare 14.4%
3 Financials 12.33%
4 Consumer Discretionary 7.88%
5 Industrials 7.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MSGS icon
401
Madison Square Garden
MSGS
$9.58B
$785K 0.01%
15,250
-17,456
-53% -$960K
TIME
402
DELISTED
Time Inc.
TIME
$785K 0.01%
+41,186
New +$871K
ALOG
403
DELISTED
Analogic Corp
ALOG
$781K 0.01%
9,523
-671
-7% -$54.4K
CUNB
404
DELISTED
CU Bancorp
CUNB
$771K 0.01%
34,322
KG
405
Kestrel Group
KG
$68M
$770K 0.01%
2,774
PLOW icon
406
Douglas Dynamics
PLOW
$1.04B
$769K 0.01%
38,735
SPB icon
407
Spectrum Brands
SPB
$2.08B
$741K 0.01%
8,100
AVY icon
408
Avery Dennison
AVY
$12.9B
$740K 0.01%
13,082
-10,019
-43% -$605K
AGO icon
409
Assured Guaranty
AGO
$3.79B
$734K 0.01%
+29,350
New +$738K
QVCGA
410
DELISTED
QVC Group Inc Series A
QVCGA
$726K 0.01%
+570
New +$781K
STE icon
411
Steris
STE
$22.4B
$724K 0.01%
11,148
-3,264
-23% -$216K
NWBI icon
412
Northwest Bancshares
NWBI
$2.33B
$723K 0.01%
55,622
+34,111
+159% +$435K
ISBC
413
DELISTED
Investors Bancorp, Inc.
ISBC
$722K 0.01%
58,533
-2,030
-3% -$24.6K
USNA icon
414
Usana Health Sciences
USNA
$429M
$684K 0.01%
+10,208
New +$722K
CTSH icon
415
Cognizant
CTSH
$23.8B
$683K 0.01%
+10,903
New +$684K
PFSI icon
416
PennyMac Financial
PFSI
$4.45B
$680K 0.01%
42,530
PFSW
417
DELISTED
PFSweb, Inc.
PFSW
$678K 0.01%
+47,722
New +$627K
SWX icon
418
Southwest Gas
SWX
$6.7B
$677K 0.01%
+11,602
New +$641K
LSAK icon
419
Lesaka Technologies
LSAK
$392M
$661K 0.01%
39,508
-10,752
-21% -$204K
UVV icon
420
Universal Corp
UVV
$1.36B
$658K 0.01%
13,286
+9,300
+233% +$488K
PSG
421
DELISTED
Performance Sports Group Ltd.
PSG
$653K 0.01%
+48,659
New +$739K
TXMD icon
422
TherapeuticsMD
TXMD
$23.8M
$650K 0.01%
+2,218
New +$788K
UDF
423
DELISTED
UNITED DEV FDG IV COM SHS OF BENE INT (TX)
UDF
$643K 0.01%
+36,510
New +$648K
GLRE icon
424
Greenlight Captial
GLRE
$586M
$636K 0.01%
28,509
SRGA
425
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
$631K 0.01%
3,702

Similar funds

Analytic Investors's Q3 2015 Portfolio in Review

As of Q3 2015, Analytic Investors held 699 positions worth $7.48B, up 5% from $7.12B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Analytic Investors deployed $584M of net new capital in Q3 2015, opening 142 new positions and adding to 200 existing holdings. Its largest new stake was Sysco: 2,156,702 shares worth $84M.

By sector, the portfolio is most concentrated in Consumer Staples at 31% of assets, up from 27% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Merck, an estimated $91.5M trimmed.

  • Analytic Investors's largest Q3 2015 buy was Sysco: 2,156,702 shares worth $84M.
  • Analytic Investors added most to McCormick & Company Non-Voting in Q3 2015, an estimated $89.6M increase.
  • Analytic Investors's biggest Q3 2015 reduction was Merck, cutting an estimated $91.5M.
  • Analytic Investors fully exited OMNICARE INC in Q3 2015, selling an estimated $31.3M.
  • Analytic Investors's ten largest holdings make up 21% of its $7.48B portfolio in Q3 2015.
  • Analytic Investors opened 142 new positions and closed 156 in Q3 2015.
  • Analytic Investors's portfolio value rose 5% quarter-over-quarter to $7.48B.

Based on Analytic Investors's 13F filing for Q3 2015, filed 12 Nov 2015.